Implications of the SEQUOIA Trial Results of Zanubrutinib/Venetoclax in CLL/SLL
December 13th 2021Jennifer R. Brown, MD, PhD, discusses the implications of the SEQUOIA trial, which looked at the combination of zanubrutinib and venetoclax for the treatment of patients with treatment-naïve chronic lymphocytic leukemia or small lymphocytic lymphoma.
Watch